Related Experiment Video
Updated: Aug 9, 2026
09:35
Real Time Measurements of Membrane Protein:Receptor Interactions Using Surface Plasmon Resonance (SPR)
Published on: November 29, 2014
Model-independent method of analyzing input in linear pharmacokinetic systems having polyexponential impulse response
Journal of Pharmaceutical Sciences
|March 1, 1980
Summary
This study introduces a novel deconvolution method for linear pharmacokinetic systems. It enables accurate drug input rate evaluation without kinetic models, using only blood concentration data.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Systems Biology
- Mathematical Modeling in Biology
Background:
- Accurate assessment of drug input into the systemic circulation is crucial for effective therapeutic strategies.
- Traditional methods often rely on specific kinetic models or precise sampling times, limiting their applicability.
- Evaluating drug input independently of disposition kinetics presents a significant challenge in pharmacokinetics.
Purpose of the Study:
- To develop a model-independent method for determining the input rate of drugs into the systemic circulation.
- To enable the evaluation of drug input using only blood concentration data, irrespective of administration route or sampling schedule.
- To provide a versatile deconvolution technique applicable to linear pharmacokinetic systems.
Main Methods:
- Development of rigorous mathematical treatment for linear compartmental systems.
- Utilizing blood drug concentration data from disposition and input experiments.
- Application of deconvolution principles without assuming a specific kinetic model.
- Merging disposition and input experiments to eliminate washout periods.
Main Results:
- A method is presented to evaluate drug input rate without a predefined kinetic model.
- The method accommodates intravenous bolus and infusion inputs, individually or in combination.
- No specific sampling times are required; only blood drug concentration data are necessary.
- Model-independent calculation of optimal drug input control for desired concentration profiles is enabled.
Conclusions:
- The developed deconvolution method offers a robust approach for pharmacokinetic analysis.
- It significantly simplifies the evaluation of drug input rates, enhancing therapeutic drug monitoring.
- This technique is broadly applicable to linear pharmacokinetic systems with polyexponential impulse responses.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
01:13Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
01:14Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...